2 unknown. 1 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
Follow LintonPharm Co.,Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Catumaxomab in Patients With Non-Muscle-Invasive Bladder Cancer Who Have Failed or Are Intolerant to BCG Vaccine Catumaxomab - Bladder Cancer | Phase 1 / Phase 2 | Unknown | LintonPharm Co.,Ltd. | 161 | 2021-11-23 | 2023-02-13 |
| Comparing the Efficacy and Safety of Intra-peritoneal Infusion of Catumaxomab and Treatment of Investigator Choice in Patients With Advanced Gastric Carcinoma With Peritoneal Metastasis Catumaxomab, The treatment of investigator choice - Stomach Neoplasms | Phase 3 | Unknown | LintonPharm Co.,Ltd. | 282 | 2020-10-06 | 2023-01-31 |
Stomach Neoplasms (1) · Urinary Bladder Neoplasms (1)
catumaxomab (2)
China (2) · South Korea (1) · Taiwan (1)